Where is eFFECTOR headquartered?

eFFECTOR is located in Solana Beach, CA.

Who invested in eFFECTOR?

eFFECTOR has 13 investors including Geekdom Fund And Geekdom Fund.

When was the last funding round for eFFECTOR?

eFFECTOR closed its lastf unding roundon Jul 19, 2017 from a Convertible Note round.

Company Information
Company Timeline (Coming Soon)

effector.com

eFFECTOR

eFFECTOR is a California-based biopharmaceutical company that develops and commercializes small molecule therapeutics for the treatment of cancer.

Business Model:

Revenue: $1.4M

Employees: 2-10

Geographic Data

Address: 142 North Cedros Avenue

City: Solana Beach

State: CA

Zip: 92075

Country: US

Financial Info

Stage:

post ipo equity

Raised Last:

$60M

Raised Total:

$220M

Social

Facebook

Twitter

Crunchbase

Metrics

3,022,348Website Global Rank

5,758Website Monthly Traffic

Twitter Followers

Description

eFFECTOR is a California-based biopharmaceutical company that develops and commercializes small molecule therapeutics for the treatment of cancer.

Contact Phone:
+18589258215

Contact Email:

IPO Details

eFFECTOR went public on 8/26/2021 on the NASDAQ

Listed Exchange:
NASDAQ

IPO Date:
8/26/2021

IPO Valuation:
$419M

Ticker Symbol:
EFTR

Amount Raised:
$175M

Live

Opened: -/share

EBITDA	-
Total Cash	-
Total Debt	-
Total Revenue	-
Total Profit (Gross)	-
PE Ratio	-

Investments

Announced Date	Company	Transaction	Money Raised

Funding Rounds

Announced Date	Transaction	Number of Investors	Money Raised	Lead Investors
2/2016	Series B	1	$16M	Sectoral Asset Management Sectoral Asset Management
5/2013	Series A	7	$45M	Abingworth Astellas Venture Management Mission Bay Capital Novartis Venture Fund OUP (Osage University Partners) SR One U.S. Venture Partners Abingworth Astellas Venture Management Mission Bay Capital Novartis Venture Fund OUP (Osage University Partners) SR One U.S. Venture Partners
12/2015	Series B	11	$40M	AbbVie Biotech Ventures Abingworth Altitude Life Science Ventures Astellas Venture Management BioMed Ventures Mission Bay Capital Novartis Venture Fund OUP (Osage University Partners) SR One The Column Group U.S. Venture Partners AbbVie Biotech Ventures Abingworth Altitude Life Science Ventures Astellas Venture Management BioMed Ventures Mission Bay Capital Novartis Venture Fund OUP (Osage University Partners) SR One The Column Group U.S. Venture Partners
8/2021	Post-IPO Equity		$0	Abingworth Alexandria Venture Investments Altitude Life Science Ventures BioMed Ventures OUP (Osage University Partners) Pfizer Venture Investments Sectoral Asset Management SR One The Column Group U.S. Venture Partners Abingworth Alexandria Venture Investments Altitude Life Science Ventures BioMed Ventures OUP (Osage University Partners) Pfizer Venture Investments Sectoral Asset Management SR One The Column Group U.S. Venture Partners
7/2017	Series C	14	$38.6M	AbbVie Biotech Ventures Abingworth Alexandria Venture Investments Altitude Life Science Ventures Astellas Venture Management BioMed Ventures Mission BioCapital Novartis Venture Fund OUP (Osage University Partners) Pfizer Venture Investments Sectoral Asset Management SR One The Column Group U.S. Venture Partners AbbVie Biotech Ventures Abingworth Alexandria Venture Investments Altitude Life Science Ventures Astellas Venture Management BioMed Ventures Mission BioCapital Novartis Venture Fund OUP (Osage University Partners) Pfizer Venture Investments Sectoral Asset Management SR One The Column Group U.S. Venture Partners
5/2019	Venture Round		$20.4M
5/2021	PIPE		$60M	Abingworth S.R. One The Column Group U.S. Venture Partners Altitude Life Science Ventures Sectoral Asset Management Alexandria Venture Investments BioMed Ventures Osage University Partners
7/2017	Series C		$16.8M	U.S. Venture Partners Abingworth SR One The Column Group Altitude Life Science Ventures Sectoral Asset Management BioMed Ventures Astellas Ventures Alexandria Venture Investments Novartis Venture Fund
1/2022	Post-IPO Equity		$50M	Lincoln Park Capital
4/2019	Series C		$20.4M	The Column Group LLC S.R. One Abingworth vc U.S Venture partners Altitude Life Science Ventures Sectoral Asset Management
8/2021	Post-IPO Equity	10	$60M	Abingworth Alexandria Venture Investments Altitude Life Science Ventures BioMed Ventures OUP (Osage University Partners) Pfizer Venture Investments Sectoral Asset Management SR One The Column Group U.S. Venture Partners Abingworth Alexandria Venture Investments Altitude Life Science Ventures BioMed Ventures OUP (Osage University Partners) Pfizer Venture Investments Sectoral Asset Management SR One The Column Group U.S. Venture Partners

Acquisitions

Announced Date	Name	Price

Employee Demographics

Employee Departments

Employee States

Similar Companies

Uniview Singapore VEID	Revenue: 0 - 100000 Employees: Industry: Software	Details
Konkuk University Medical Center	Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education	Details
Daemon Technologies	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain	Details
Ace International Trade	Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial	Details
An Hòa Communications	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising	Details